Literature DB >> 6745739

Further evidence of prolactin production from human decidua and its transport across fetal membrane.

Y Fukamatsu, K Tomita, T Fukuta.   

Abstract

In this study the human decidua, chorion and amnion were incubated for short term. Only the decidua, secreted much prolactin clearly among them as a function of time. When the amounts of prolactin in the maternal blood, cord blood obtained from umbilical vein, or those released into decidual incubation medium were compared with the amniotic fluid prolactin levels, only the decidual prolactin correlated significantly with the amniotic fluid prolactin. The urine obtained from newborns showed a low concentration of prolactin. These results suggest that the origin of prolactin present in the amniotic fluid is not from the mother or fetus, but from the decidua which has the ability of producing prolactin, and that prolactin secreted from this tissue may be transported into the amniotic fluid through the fetal membrane and accumulated there.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6745739     DOI: 10.1159/000299168

Source DB:  PubMed          Journal:  Gynecol Obstet Invest        ISSN: 0378-7346            Impact factor:   2.031


  4 in total

Review 1.  Prolactin and its significance in the placenta.

Authors:  Meenakshi Rana; Sidhant Jain; Pooja Choubey
Journal:  Hormones (Athens)       Date:  2022-05-11       Impact factor: 2.885

2.  Amniotic fluid prolactin, decidual prolactin content and decidual prolactin secretion into hypo-, iso-, and sodium chloride hyperosmotic media in vitro in pregnant diabetics at term.

Authors:  J R Andersen; B Borggaard; E B Olsen; H Stimpel; H C Nyholm; E Schroeder
Journal:  Acta Diabetol Lat       Date:  1986 Oct-Dec

Review 3.  Maternal influence in the transmission of asthma susceptibility.

Authors:  Edward G Barrett
Journal:  Pulm Pharmacol Ther       Date:  2007-07-12       Impact factor: 3.410

Review 4.  Risk factors for food allergy.

Authors:  Diane E Schuller
Journal:  Curr Allergy Asthma Rep       Date:  2004-11       Impact factor: 4.919

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.